Ticker Details
Galecto, Inc. Common Stock
IPO Date:	October 29, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.81B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.24 | 4.13%
Avg Daily Range (30 D):	$1.37 | 5.71%
Avg Daily Range (90 D):	$1.43 | 6.69%

Institutional Daily Volume
Avg Daily Volume:	.21M
Avg Daily Volume (30 D):	.19M
Avg Daily Volume (90 D):	.81M

Trade Size
Avg Trade Size (Sh.):	52
Avg Trade Size (Sh.) (30 D):	122
Avg Trade Size (Sh.) (90 D):	56

Institutional Trades
Total Institutional Trades:	65
Avg Institutional Trade:	$2.1M
Avg Institutional Trade (30 D):	$3M
Avg Institutional Trade (90 D):	$2.38M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$2.78M
Avg Closing Trade (30 D):	$4.23M
Avg Closing Trade (90 D):	$3.17M
Avg Closing Volume:	87.3K

News

Feb 12, 2026 @ 9:01 PM Galecto Announces Closing of Public Offering and F... Source: Globe Newswire

Feb 11, 2026 @ 3:42 AM Galecto Announces Pricing of $275 Million Underwri... Source: Na

Dec 16, 2025 @ 10:00 PM Galecto, Inc. Announces Inducement Grant Under Nas... Source: Galecto, Inc.

Nov 10, 2025 @ 4:47 PM Galecto Stock Soars: Strengthens Blood Cancer Pipe... Source: Vandana Singh

Nov 10, 2025 @ 12:00 PM Galecto Announces Acquisition of Damora Therapeuti... Source: Galecto, Inc.

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-12.11	$-2.36	$-2.6
Diluted EPS	$-12.11	$-2.36	$-2.6
Revenue	$.39M	$.04M	$.05M
Gross Profit
Net Income / Loss	$-15.84M	$-3.1M	$-3.4M
Operating Income / Loss	$-16.28M	$-3.16M	$-3.42M
Cost of Revenue
Net Cash Flow	$-6M	$-2.61M	$-1.73M
PE Ratio

Splits
Aug 30, 2024	1:25